Protocol summary

Study aim
Effect of prescription of drugs on acute complications of Transurethral Lithotripsy
Design
In this parallel clinical trial, block randomization is performed using an online program. In phase 3, 3 medications and a placebo are used to assess the efficacy of different medications in decreasing transurethral lithotripsy complications in 400 patients.
Settings and conduct
In this study, at Sina Hospital in Tehran, patients who are candidates for transurethral lithotripsy are randomly and blindly divided into four groups, and with three drugs in three groups and in group four without drugs, the prevalence of intervention complications is assessed.
Participants/Inclusion and exclusion criteria
Inclusion criteria: TUL candidate patients Exclusion criteria: Previous ureteral manipulation Having a DJ (Double J) or ureteral catheter Creatinine above 1.5 mg / dL Age over 65 years Weight less than 50 kg Contraindications or allergies to prescribed drugs Patients who are taking one of the above three drugs for any reason before seeking TUL. Patient dissatisfaction with participating in the research project
Intervention groups
Four drug groups (tamsulosin, serum normal saline, ketorolac, and hyoscine) The first group received only one liter of normal saline (placebo) before TUL. The second group received tamsulosin capsules two nights before surgery. The third group received ketorolac before TUL with one liter of normal saline at least one hour before surgery. The fourth group received an ampoule of hyoscine with one liter of normal saline at least one hour before TUL.
Main outcome variables
Bladder injury, Ureterovesical junction injury, ureteral mucosa elevation, ureteral perforation, inability to reach the ureteral stone, inability to enter the ureter, ureteral avulsion, and need for a narrower ureteroscope

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20161221031505N1
Registration date: 2022-06-25, 1401/04/04
Registration timing: prospective

Last update: 2022-06-25, 1401/04/04
Update count: 0
Registration date
2022-06-25, 1401/04/04
Registrant information
Name
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 556585015
Email address
h-akhavizadegan@tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-07-23, 1401/05/01
Expected recruitment end date
2023-03-20, 1401/12/29
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison the effect of single dose medication in decreasing urgent ureteroscopy complications, a double blind randomized clinical trial
Public title
Assessing the efficacy of different medications in decreasing complications of transureteral lithotripsy
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Candidates of transureteral lithotripsy
Exclusion criteria:
Renal dysfunction, Creatinine more than 1.5 mg/dl Previous ureteral intervention Having Double J or ureteral catheter age higher than 65 Weight less than 50 kg Contraindication or allergy to medications used in project History of using medications before intervention Patient does not want to participate in study
Age
From 18 years old to 65 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 400
Randomization (investigator's opinion)
Randomized
Randomization description
Block randomization In this section using the site (https://www.sealedenvelope.com/simple-randomiser/v1/lists) randomization is done with quadruple blocks (equal to the number of groups). The list of each of four patients is entered in a block, respectively. The first and second-year urology assistants who are responsible for preparing the patient in the urology ward will give the necessary dose to the patient and record it and then the patient is transported to the operating room without knowing about the medicine received.
Blinding (investigator's opinion)
Double blinded
Blinding description
The medication is prescribed and registered by the first-year assistant in the ward without mentioning its name to the patient and the stone crushing is done by the third-year assistant in the operating room without knowing the medication.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethical committee of Tehran University of Medical Sciences
Street address
Sina hospital, Hasn Abad square,
City
Tehran
Province
Tehran
Postal code
1136746911
Approval date
2020-08-27, 1399/06/06
Ethics committee reference number
IR.TUMS.MEDICINE.REC.1399.371

Health conditions studied

1

Description of health condition studied
Ureteral stone
ICD-10 code
ICD-10 code description
N 21

Primary outcomes

1

Description
Reducing damage to the bladder
Timepoint
During TUL
Method of measurement
Observing procedure

2

Description
Reducing damage to the ureteral entrance to the bladder
Timepoint
During TUL
Method of measurement
Observing procedure

3

Description
Reducing ureteral mucosa injury
Timepoint
During transurethral lithotripsy
Method of measurement
Observing the procedure

4

Description
Reducing ureteral perforation
Timepoint
During transurethral lithotripsy
Method of measurement
Observing the procedure

5

Description
Reducing ureteral stone riching failure
Timepoint
During transurethral lithotripsy
Method of measurement
Observation the procedure

6

Description
Reducing inability to enter the ureter
Timepoint
During transurethral lithotripsy
Method of measurement
Observation during procedure

7

Description
Reducing ureteral avulsion
Timepoint
During transurethral lithotripsy
Method of measurement
Observing during procedure

8

Description
Reducing the need for a narrower ureteroscope
Timepoint
During transurethral lithotripsy
Method of measurement
Observing during procedure

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group number 1: 1 amp. Hyoscine 20 mg made by Exir company diluted in one liter normal saline is infused via vein catheter 1 hour before intervention.
Category
Treatment - Drugs

2

Description
Intervention group number 2: 1 amp. ketorolac 30 mg made by Exir company diluted in one liter normal saline is infused via vein catheter 1 hour before intervention.
Category
Treatment - Drugs

3

Description
Intervention group number 3: 2 caps. Tamsulosin made by Exir company is prescribed for the patient and tomorrow one liter normal saline is infused via vein catheter during one hour before surgery.
Category
Treatment - Drugs

4

Description
Control group or intervention 4: 1 liter normal saline is infused one hour before surgery.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Sina hospital
Full name of responsible person
Hamed Akhavizadegan
Street address
Hasan abad Square
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6312 1538
Fax
+98 21 6312 1538
Email
h-akhavizadegan@tums.ac.ir
Web page address
https://sinahospital.tums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Shahin Akhoondzadeh
Street address
Research Deputy office, Tehran University of Medical Sciences, Boulevard Keshavarz
City
Tehran
Province
Tehran
Postal code
1417613151
Phone
+98 21 6312 1538
Fax
+98 21 6312 1538
Email
h-akhavizadegan@tums.ac.ir
Web page address
https://tums.ac.ir/
Grant name
-
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tehran University of Medical Sciences
Proportion provided by this source
30
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Hamed Akhavizadegan
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Urology
Street address
Hasan Abad square, Sina hospital
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6312 1538
Fax
+98 21 6312 1538
Email
h-akhavizadegan@tums.ac.ir
Web page address
https://sinahospital.tums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Hamed Akhavizadegan
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Urology
Street address
Sina hospital, Hasan abad square
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6312 1538
Fax
+98 21 6312 1538
Email
h-akhavizadegan@tums.ac.ir
Web page address
https://sinahospital.tums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Hamed Akhavizadegan
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Urology
Street address
Hasan Abad square, Sina hospital
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6312 1538
Fax
+98 21 6312 1538
Email
h-akhavizadegan@tums.ac.ir
Web page address
https://sinahospital.tums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
All data will be provided to the Vice-Chancellor for Research of Tehran University of Medical Sciences as a dissertation
When the data will become available and for how long
6 months after the publication of the article
To whom data/document is available
Scientific institutes and researchers
Under which criteria data/document could be used
To share experiences and increase citations
From where data/document is obtainable
To the e-mail address of Dr. Hamed Akhvizadegan (h-akhavizadegan@tums.ac.ir)
What processes are involved for a request to access data/document
Up to one month after the email and review of the application and then obtaining the license of the Vice Chancellor for Research, information will be provided to the person.
Comments
In addition, because the research is a dissertation, a copy of it is available to the public in the Central Library as well as in the library of Sina Hospital.
Loading...